// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























914 Abstracts

Hydroxylase as a Therapeutic Target in Idiopathic Pulmonary Fibrosis

B. Gary - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

roxadustat

Responsive Element Regulatory System in Idiopathic Pulmonary Fibrosis

C. Huang - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Idiopathic pulmonary fibrosis

Ferric ammonium citrate

Fibrotic Effects of Pirfenidone

K. G. Dsouza - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

DE-074

Nintedanib: A Potent Inhibitor of Invadosome Formation by Lung Fibroblasts Derived from Patients with Idiopathic Pulmonary Fibrosis

M. Lebel - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Nintedanib

3 in Idiopathic Pulmonary Fibrosis Development

N. R. Parmar - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Homer1 Is Increased in Idiopathic Pulmonary Fibrosis and Affects Fibroblasts Behavior

M. Negreros - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

92 Are Disease Specifically Regulated in Fibroblasts of Idiopathic Pulmonary Fibrosis

C. Lambers - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bisphenol A

Integrin A5 (ITGA5) Promotes Cellular Responses Facilitating Idiopathic Pulmonary Fibrosis (IPF) Progression

G. Epstein Shochet - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

DE-074

Mediated Pulmonary Vascular Remodeling

A. J. Bryant - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Fibrotic microRNA of Fibrocytes in Bronchoalveolar Lavage Fluid

S. Sato - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Idiopathic pulmonary fibrosis

DE-074

Derived Exosomes Contain Profibrotic miRNAs Consistent with Serum miRNAs from Patients with Idiopathic Pulmonary Fibrosis

S. Chong - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Expression Analysis of Serum microRNAs in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

K. Oda - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Pudlak Syndrome Pulmonary Fibrosis

B. R. Gochuico - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Protein C

Epigenetic Age Acceleration in Idiopathic Pulmonary Fibrosis

D. Kurbanov - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Analysis of Polymorphism in ATG16L1 Gene and the Risk to Idiopathic Pulmonary Fibrosis

L. Laguna - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Frequency of Single Nucleotide Polymorphisms of Five Genes in Idiopathic Pulmonary Fibrosis Patients Treated with Pirfenidone

W. H. Amundson - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Pirfenidone

Bronchoalveolar Cell Transcriptome of Acute Exacerbation in Idiopathic Pulmonary Fibrosis

A. Prasse - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Derived Microparticles as a Biomarker in Pulmonary Fibrosis: A Pilot Study

T. Neri - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Phosphatidylserine

Role of ZNF365 in Pulmonary Fibrosis

J. M. Pérez Huacuja Urista - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Mitochondrial Crosstalk in the Development of Idiopathic Pulmonary Fibrosis

J. Knoell - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Amiodarone Hydrochloride

Copyright © 2026. QuantiNova All rights reserved